Wilson–Turner syndrome

Wilson-Turner Syndrome
Classification and external resources
Specialty Medical genetics, pediatrics, psychiatry, rare diseases, metabolic diseases, endocrine diseases, mental diseases
OMIM 309585

Wilson-Turner Syndrome (WTS), also known as Mental Retardation X Linked Syndromic 6 (MRXS6), or Mental Retardation X Linked with Gynecomastia and Obesity is a congenital condition characterized by intellectual disability and associated with childhood-onset obesity.[1] It is found to be linked to the X chromosome and caused by a mutation in the HDAC8 gene, which is located on the q arm at locus 13.1. Individuals with Wilson–Turner syndrome have a spectrum of physical characteristics including dysmorphic facial feature, hypogonadism, and short stature. Females generally have milder phenotype than males. The study of X-linked mental retardation began in 1943 when Martin and Bell reported a family exhibiting sex-linked mental retardation.[2] However, this syndrome was not recognized until 1991. Wilson studied 14 males from 3 successive generations that presented hypogonadism, mental retardation, gynecomastia, short stature, among other symptoms.[3] Eventually, this disorder was ruled distinct from a syndrome presented by Prader and Willi (Prader-Willi syndrome) because of its mode of inheritance, gynecomastia, and presence of small hands and feet.[4] However, there are some speculations that this syndrome is in the same spectrum as the Cornelia de Lange syndrome.[5] This disorder affects all demographics equally and is seen in less than one in one million people.[6]

Symptoms

The most notable features of Wilson-Turner Syndrome are intellectual disability, obesity, hypogonadism, gynecomastia, and distinct facial features. All of the symptoms are chronic. Affected females are known to have less severe signs and symptoms than males. Female carriers of the disorder may have none or mild symptoms.

Causes and Prevention

Causes

The only known cause of this disorder is the mutation on the HDAC8 gene, which is located at Xq13.1. This disorder displays X-linked inheritance

Screening

Screening methods are mostly done for females to determine if they are carriers. Males do not have to be tested because those with the disorder will show symptoms close to the time they are born because the disorder is inherited from the X chromosome. Female can be tested if they are carriers by performing a X chromosome inactivation analysis on DNA isolated from the peripheral lymphocytes. The CAG repeat in this section must be amplified and methylated DNA must be sorted from unmethylated DNA with PCR. Carrier females will show skewed X-inactivation pattern (skewing close to 100%) with the mutated allele inactivated. This indicates a selection against cells with an active X chromosome with the mutated HDAC8 gene.[1]

Demographics

This disorder affects all demographics equally. The two families that were studied are of European ancestry. Wilson–Turner syndrome is considered to be a rare disease because it affects one individual out of one million.[6]

Mechanism

Pathophysiology

The primary symptoms of Wilson-Turner Syndrome is believed to result from an improperly developed histone deacetylase 8. This enzyme is coded by the HDAC8 gene. The identified mutation in the HDAC8 gene leads to a version of histone deacetylase 8 that is missing a segment. Histone deacetylase 8 is believed to be a regulator of the cohesion complex, playing a role in stabilizing the cell’s genetic information, repairing damaged DNA, and controlling gene activity. This abnormally shortened protein alters gene regulations during the individual’s normal development. Some of the effected normal development lies in the endocrine system. Males will have more estrogen and androgen than normal, leading to enlarged hypogonadism and gynecomastia. Other abnormal development is related to general mental capacity.[5] HDACs are known to be associated with human brain development disorders.[1] HDAC8, in particular, represses transcription factors in neural crest cells to control various patterns of the skull.[1] This contributes to the various forms of facial deformities in individuals with Wilson-Turner Syndrome. Some of the facial deformities caused by the HDAC8 include prominent supraorbital ridges and high cheekbones. Researchers also contribute the error in the HDAC8 gene to obesity. Since the HDAC family proteins are involved in changes in the gene expression in the hypothalamus, it is also believed that the individual’s metabolism conditions are altered.[17]

Diagnosis

Techniques

The diagnosis of Wilson–Turner syndrome is based upon a clinical evaluation, a detailed patient history, and identification of characteristic features. Molecular genetic testing for mutations in the HDAC8 gene is now available to confirm the diagnosis.

Criteria

The Wilson–Turner syndrome is characterized by mild to moderate range of intellectual disability, obesity, tapered fingers, and mood swings. Males also suffer from gynecomastia and hypogonadism. In order to be diagnosed with Wilson-Turner Syndrome, male patients must suffer from intellectual disability, obesity, and gynecomastia. Females do not necessarily have to have noticeable phenotype but can be diagnosed with this disorder by studying her family history and identifying others with the disorder. It has been noted that children with Wilson-Turner Syndrome will display speech development delay and excessive drooling. Males can be confirmed by testing androgen levels.[8] Female carriers will show silencing of the gene a complex X inactivation.[18]

Family/Medical History

Family medical history is studied in depth due to its X-linked inheritance. The families that were studied and diagnosed with Wilson-Turner Syndrome have shown X-linked recessive pedigree pattern. This disorder only have been identified in two families, thus there is still ongoing studies concerning other inherited factors that may contribute to this disorder.[18]

Treatment and Prognosis

Common Treatment

There is no known cure available for the Wilson-Turner Syndrome. Instead, treatment options are available to fight individual symptoms. For obesity, a nutritional diet manipulation is combined with an exercise regimen that has a greater energy expenditure than intake. For hypogonadism, testosterone replacement is done. Finally, for gynecomastia, weight loss using similar methods for obesity is prescribed. However, if the individual finds his increased breast tissue psychologically distressing and/or is too severe, reduction mammaplasty is done. Currently, researchers are investigating therapy using antiestrogens and aromatase inhibitors to treat persistent pubertal gynecomastia.[19]

Long-Term Complications

Unlike Borjeson-Forssman-Lehmann syndrome, a disorder that was determined to be very similar to WTS, the individuals with Wilson–Turner syndrome do not develop cataracts or hypermetropia later in life.[20] By far, the most debilitating part of this disorder is intellectual disability. Many of the other symptoms are more easily managed through hormone treatment, proper diet and exercise, and speech therapy.

Recent Research

In 2012, a 5-generation Dutch family consisting of 7 males and 7 females with Wilson-Turner Syndrome. These individuals had some characteristics that differed from the stated phenotype mentioned by Wilson. These individuals have a larger stature, head, and chin, in addition to coarse facial features. Unlike the females in Wilson's study, these females shown signs of being affected, although less severe than their male counterparts. None of the men could live on their own. Studies verified that the phenotype of the disorder range on a large scale and can affect everyone differently. This research group also used next-generation sequencing of the X chromosome exome to identify the HDAC8 gene mutation[1]

There is also ongoing research to determine the cause of the decreased or low androgen levels. It is studying the possible disturbance of the hypothalamic-pituitary-gonadal axis because of the low levels of androgen are combined with normal levels of FSH and LH.[7]

See also

Category:Intellectual disability Category:Pediatrics Category:Syndromes Category:X-linked dominant disorders Category:Neurogenetic disorders

References

  1. 1 2 3 4 5 Harakalova, Magdalena; Boogaard, Marie-Jose van den; Sinke, Richard; Lieshout, Stef van; Tuil, Marc C. van; Duran, Karen; Renkens, Ivo; Terhal, Paulien A.; Kovel, Carolien de (2012-08-01). "X-exome sequencing identifies a HDAC8 variant in a large pedigree with X-linked intellectual disability, truncal obesity, gynaecomastia, hypogonadism and unusual face". Journal of Medical Genetics. 49 (8): 539–543. doi:10.1136/jmedgenet-2012-100921. ISSN 1468-6244. PMID 22889856.
  2. "Invited Editorial: X-linked mental retardation: In pursuit of a gene map". ResearchGate. Retrieved 2015-11-01.
  3. Wilson, Meredith; Mulley, John; Gedeon, Agi; Robinson, Hazel; Turner, Gillian (1991-09-15). "New X-linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255". American Journal of Medical Genetics. 40 (4): 406–413. doi:10.1002/ajmg.1320400405. ISSN 1096-8628.
  4. Vasquez, Silvia B.; Hurst, Daniel L.; Sotos, Juan F. "X-linked hypogonadism, gynecomastia, mental retardation, short stature, and obesity—a new syndrome". The Journal of Pediatrics. 94 (1): 56–60. doi:10.1016/s0022-3476(79)80350-9.
  5. 1 2 "HDAC8 gene". Genetics Home Reference. 2015-10-19. Retrieved 2015-10-26.
  6. 1 2 "Wilson-Turner Syndrome disease: Malacards - Research Articles, Symptoms, Drugs, Genes, Clinical Trials". www.malacards.org. Retrieved 2015-10-26.
  7. 1 2 3 4 5 6 7 8 Stevenson, Roger E.; Schwartz, Charles E.; Rogers, R. Curtis; Rogers, Richard Curtis (2012-07-12). Atlas of X-Linked Intellectual Disability Syndromes. OUP USA. ISBN 9780199811793.
  8. 1 2 "Börjeson-Forssman-Lehman Syndrome - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2015-11-01.
  9. "Onion River Chiropractic - Chiropractor In Winooski, VT USA :: Truncal Obesity and Health". onionriverchiro.com. Retrieved 2015-11-02.
  10. "Hypogonadism". Healthline. Retrieved 2015-10-26.
  11. "What is Male Hypogonadism? Learn Hormone.org's Hypogonadism Definition". www.hormone.org. Retrieved 2015-10-26.
  12. Juberg, R. C.; Marsidi, I. (1980-09-01). "A new form of X-linked mental retardation with growth retardation, deafness, and microgenitalism". American Journal of Human Genetics. 32 (5): 714–722. ISSN 0002-9297. PMC 1686104Freely accessible. PMID 6107045.
  13. Niewoehner, Catherine B.; Schorer, Anna E. (2008-03-27). "Gynaecomastia and breast cancer in men". BMJ. 336 (7646): 709–713. doi:10.1136/bmj.39511.493391.BE. ISSN 0959-8138. PMC 2276281Freely accessible. PMID 18369226.
  14. Narula, Harmeet S.; Carlson, Harold E. "Gynaecomastia—pathophysiology, diagnosis and treatment". Nature Reviews Endocrinology. 10 (11): 684–698. doi:10.1038/nrendo.2014.139.
  15. Cordova, Adriana; Moschella, Francesco. "Algorithm for clinical evaluation and surgical treatment of gynaecomastia". Journal of Plastic, Reconstructive & Aesthetic Surgery. 61 (1): 41–49. doi:10.1016/j.bjps.2007.09.033.
  16. Devalia, H.L.; Layer, G.T. "Current concepts in gynaecomastia". The Surgeon. 7 (2): 114–119. doi:10.1016/s1479-666x(09)80026-7.
  17. Funato, Hiromasa; Oda, Satoko; Yokofujita, Junko; Igarashi, Hiroaki; Kuroda, Masaru (2011-04-15). "Fasting and High-Fat Diet Alter Histone Deacetylase Expression in the Medial Hypothalamus". PLoS ONE. 6 (4): e18950. doi:10.1371/journal.pone.0018950. PMC 3078138Freely accessible. PMID 21526203.
  18. 1 2 "Disease: 309585 - GenePeeks Research". research.genepeeks.com. Retrieved 2015-11-01.
  19. "Wilson-Turner X-linked mental retardation syndrome — CheckOrphan". www.checkorphan.org. Retrieved 2015-10-26.
  20. Frézal, J. (1992-12-01). "New X-linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255". American Journal of Medical Genetics. 44 (6): 854–855. doi:10.1002/ajmg.1320440637. ISSN 0148-7299. PMID 1481864.
This article is issued from Wikipedia - version of the 11/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.